https://ansm.sante.fr/informations-de-securite/arret-de-commercialisation-de-soludactone-recommandations-de-lansm 2023 false false false France French drug information drug combinations canrenoic acid canrenoate potassium aldosterone antagonists diuretics tromethamine hypokalemia
--- http://www.has-sante.fr/portail/jcms/c_2588377/fr/soludactone 2016 false France French drug combinations tromethamine canrenoate potassium intraoperative complications postoperative complications mineralocorticoid receptor antagonists canrenoic acid injections, intravenous insurance, health, reimbursement potassium canrenoate hyperaldosteronism hypokalemia hypokalemia evaluation of the transparency committee
--- http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-4899_soludactone_.pdf http://www.has-sante.fr/portail/display.jsp?id=c_614746 2007 false France French canrenoate potassium tromethamine mineralocorticoid receptor antagonists canrenoic acid injections, intravenous potassium canrenoate hyperaldosteronism hypokalemia hypokalemia evaluation of the transparency committee